Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Novo Nordisk to DKK 1,450 from DKK 1,200 and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVO:
- Novo Nordisk price target raised to DKK 1,200 from DKK 1,075 at Barclays
- Novo Nordisk raises sales and operating profit outlook for 2023
- Novo Nordisk upgraded to Outperform from Neutral at Credit Suisse
- Novo Nordisk, Aspect Biosystems announce bioprinted tissue partnership
- Novo Nordisk price target raised to DKK 1,152 from DKK 1,081 at Guggenheim